Profilo
Bruce P.
Connop is an Independent Director at IBEX Technologies, Inc. since 2017.
He is also the Vice President-Preclinical Research & Development at Active Pass Pharmaceuticals, Inc. since 1999.
Previously, he worked as the VP-Non Clinical & Pharmaceutical Development at Transition Therapeutics, Inc. from 2006 to 2012.
Dr. Connop holds a doctorate degree from Queen's University.
Posizioni attive di Bruce P. Connop
| Società | Posizione | Inizio |
|---|---|---|
| IBEX TECHNOLOGIES | Direttore/Membro del Consiglio | 11/10/2017 |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Direttore Tecnico/Scientifico/R&S | 01/01/1999 |
Precedenti posizioni note di Bruce P. Connop
| Società | Posizione | Fine |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Corporate Officer/Principal | - |
Formazione di Bruce P. Connop
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Transition Therapeutics, Inc.
Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
IBEX Technologies, Inc.
IBEX Technologies, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures specialty enzymes, diagnostic reagents & biomedical products | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Health Technology |
















